Cancers | Free Full-Text | Therapeutic Targeting of Autophagy for Renal Cell Carcinoma Therapy | HTML
Temsirolimus - Wikipedia
Targeting the phosphatidylinositol 3‐kinase/Akt/mechanistic target of rapamycin signaling pathway in B‐lineage acute lymphoblastic leukemia: An update - Simioni - 2018 - Journal of Cellular Physiology - Wiley Online Library
IJMS | Free Full-Text | The Role of mTOR Signaling as a Therapeutic Target in Cancer | HTML
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) | Leukemia
Everolimus | Nature Reviews Drug Discovery
Mechanism of action of available targeted therapies in metastatic renal... | Download Scientific Diagram
Vascular endothelial growth factor and mTOR pathways in renal cell carcinoma: differences and synergies of two targeted mechanisms - Mulders - 2009 - BJU International - Wiley Online Library
Advances in Treatment of Renal Cell Carcinoma: Evolving Role of mTOR Inhibitors Robert J. Motzer MD Memorial Sloan-Kettering Cancer Center New York, NY. - ppt download
Newly Approved mTOR Inhibitors for the Treatment of Metastatic Renal Cell Carcinoma
Treatment options for advanced pancreatic neuroendocrine tumors: what is on the horizon? | International Journal of Endocrine Oncology
mTOR inhibitors - Wikipedia
mTOR Inhibitors, with Special Focus on Temsirolimus and Similar Agents | SpringerLink
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text
Temsirolimus | Nature Reviews Drug Discovery
Mechanistic target of rapamycin inhibitors: successes and challenges as cancer therapeutics
mTOR inhibitors - Wikipedia
Systemic treatment of renal cell cancer: A comprehensive review - ScienceDirect
Frontiers | The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside | Oncology